Medication & Safety
Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
Most people can take these drugs safely. A small number genuinely should not, and a larger group needs specific precautions rather than a blanket refusal.
Nearly all of it is identifiable before treatment starts, from history and a few questions. That is the entire purpose of a medical review, and it is what an informal purchase skips.
Absolute contraindications
These mean the drug is not used, rather than used carefully.
Medullary thyroid carcinoma or MEN2
A personal or family history of medullary thyroid carcinoma, or of multiple endocrine neoplasia syndrome type 2, rules out every GLP-1 receptor agonist.
This comes from rodent studies showing thyroid C-cell tumours. Whether that translates to humans is not established, and nearly two decades of use has not produced a clear human signal. The contraindication remains because the potential consequence is severe.
Family history matters, not only your own. This is a question people frequently cannot answer without asking relatives, and it is worth doing.
Previous pancreatitis
A history of pancreatitis is the strongest predictor of pancreatitis recurrence, and these drugs are generally avoided.
Pregnancy and breastfeeding
Not used during pregnancy. Animal studies showed adverse developmental effects and human safety data is insufficient. Deliberate weight loss during pregnancy is also not appropriate.
Guidance is to stop before planned conception, with the interval depending on the drug. Semaglutide has a long half-life so the washout is not brief.
Not used while breastfeeding.
Type 1 diabetes and diabetic ketoacidosis
These drugs are not a substitute for insulin in type 1 diabetes.
Known hypersensitivity to the drug or its components.
Conditions requiring specific caution
Not automatic exclusions, but they change the assessment and need a doctor involved.
Gallstones or previous gallbladder disease. The JAMA Internal Medicine meta-analysis of 76 trials and 103,371 patients found a relative risk of 1.37 for gallbladder or biliary disease, rising to 2.29 when used for weight loss. Existing stones raise that further.
Gastroparesis or significant delayed gastric emptying. Slowing an already slowed stomach is the wrong direction.
Severe kidney impairment. Some drugs need dose adjustment. Exenatide specifically is cleared by the kidneys and is not used in severe impairment.
Diabetic retinopathy. Rapid blood sugar improvement can temporarily worsen existing retinopathy. Monitoring is needed.
Inflammatory bowel disease or significant gastrointestinal disease, given the drug class effects.
Severe heart failure, requiring individual assessment.
Eating disorders. A history of anorexia, bulimia or restrictive eating needs careful evaluation. Appetite suppression in someone with a restrictive eating disorder is potentially harmful.
Under 18. Some products have adolescent indications in specific circumstances, but this is a specialist decision rather than a general one.
Medications requiring adjustment
Not contraindications, but they need managing.
Insulin and sulfonylureas such as gliclazide and glimepiride. Doses usually need reducing to avoid hypoglycaemia.
Oral contraceptives, particularly with tirzepatide, which can reduce absorption around dose increases.
Warfarin, needing closer INR monitoring.
Levothyroxine, where absorption may change.
Blood pressure medication, which frequently needs reducing as weight falls.
Diuretics, ACE inhibitors, ARBs and NSAIDs, which raise kidney risk during dehydration from vomiting or diarrhoea.
Situations where it is the wrong tool
Different from being unsafe. These are cases where the medication does not address the problem.
BMI in the healthy range. These are not cosmetic products, and appetite suppression in someone who does not need weight loss carries risk without benefit.
Eating driven by emotion rather than hunger. If stress, boredom or sadness drive your eating, appetite suppression addresses the wrong mechanism. Psychological support may serve better.
Wanting rapid loss for a specific event. Trial results describe 56 to 72 weeks. This is not a short-term intervention.
Not having tried the free changes. Portion order, plate size, cutting liquid sugar, walking and sleep all cost nothing. Medication before those is spending to avoid changes you will need anyway.
Undiagnosed underlying cause. If hypothyroidism, PCOS or a medication is driving weight gain, a diagnosis addresses the actual problem.
Age considerations
Older adults are not excluded, and SELECT enrolled adults aged 45 and over, demonstrating cardiovascular benefit. But dehydration risk is higher, muscle loss matters more given sarcopenia risk, and polypharmacy makes interactions more likely.
Adolescents need specialist assessment rather than general prescribing.
Why this list is the argument for review
Read back through it. Family history of a rare thyroid cancer. Previous pancreatitis. Gallstones. Pregnancy plans. Current medications. Eating disorder history. Kidney function.
None of these is visible. They come from asking, and from someone knowing which questions matter.
In Pakistan, where no GLP-1 medication is registered and everything arrives through informal import, a purchase involves no questions at all. Someone with a family history of medullary thyroid carcinoma, or a previous episode of pancreatitis, buys and injects without anyone establishing either.
Physician-reviewed sublingual drops include that history-taking before dispatch. METASLIM™ is a physician-reviewed supplement rather than a pharmaceutical GLP-1 receptor agonist, and it is also not used in pregnancy, breastfeeding or under 18.
The screening step is the point. Our page on why physician oversight matters covers what it involves, and drug interactions covers the medication side in detail.
The summary
Absolute contraindications are a personal or family history of medullary thyroid carcinoma or MEN2, previous pancreatitis, pregnancy, breastfeeding, type 1 diabetes and known hypersensitivity.
Specific caution applies with gallstones, gastroparesis, severe kidney impairment, diabetic retinopathy, inflammatory bowel disease, severe heart failure and eating disorder history.
Insulin, sulfonylureas, oral contraceptives, warfarin, levothyroxine and blood pressure medication all need review or adjustment.
Some situations make it the wrong tool rather than unsafe, including healthy BMI, emotion-driven eating and untried free changes.
Family history matters, not only your own, and many people need to ask relatives.
Get started with a physician review so this list is worked through before you begin.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.